Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - P/B ratio
P/B ratio as of May 2024 : 0.9222
According to Titan Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.9222.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Titan Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9357 | -88.87% |
| 2022-12-31 | 8.41 | 327.05% |
| 2021-12-31 | 1.97 | -68.23% |
| 2020-12-31 | 6.19 | -20.3% |
| 2019-12-31 | 7.77 | 204.98% |
| 2018-12-31 | 2.55 | -92.23% |
| 2017-12-31 | 32.8 | 409.98% |
| 2016-12-31 | 6.43 | -49.55% |
| 2015-12-31 | 12.7 | 115.9% |
| 2014-12-31 | 5.90 | -36.72% |
| 2013-12-31 | 9.33 | -360.71% |
| 2012-12-31 | -3.58 | 6.1% |
| 2011-12-31 | -3.37 | -71.05% |
| 2010-12-31 | -11.6 | -98.21% |
| 2009-12-31 | -650 | -453629.28% |
| 2008-12-31 | 0.1434 | -94.95% |
| 2007-12-31 | 2.84 | -74.38% |
| 2006-12-31 | 11.1 | 295.81% |
| 2005-12-31 | 2.80 | -5.82% |
| 2004-12-31 | 2.98 | 61.17% |
| 2003-12-31 | 1.85 | 236.21% |
| 2002-12-31 | 0.5491 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.25 | 468.88% | 🇺🇸 USA |
 Novartis NVS | 5.00 | 441.72% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | 0.4942 | -46.42% | 🇺🇸 USA |
 Repligen
RGEN | 4.71 | 410.84% | 🇺🇸 USA |
 MediciNova MNOV | 1.09 | 17.66% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 6.28 | 580.44% | 🇺🇸 USA |